D. Snydman

发表

Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities.

A. Steere, S. Malawista, D. Snydman, 1977, Arthritis and rheumatism.

Update and review: state-of-the-art management of cytomegalovirus infection and disease following thoracic organ transplantation.

D. Snydman, A. Limaye, L. Potena, 2011, Transplantation proceedings.

Preventing post-organ transplantation cytomegalovirus disease with ganciclovir: a meta-analysis comparing prophylactic and preemptive therapies.

D. Snydman, J. Lau, L. Small, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The safety of probiotics.

D. Snydman, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Trends in antimicrobial resistance among Bacteroides species and Parabacteroides species in the United States from 2010-2012 with comparison to 2008-2009.

D. Snydman, Robin Patel, E. Goldstein, 2017, Anaerobe.

Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia.

D. Snydman, V. Yu, N. Zealand., 1998, The Journal of infectious diseases.

Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit.

D. Snydman, R. Ruthazer, Robin Ruthazer, 2003, Archives of internal medicine.

Antimicrobial susceptibility and ribotypes of Clostridium difficile isolates from a Phase 2 clinical trial of ridinilazole (SMT19969) and vancomycin

D. Snydman, S. Walk, L. Mcdermott, 2018, The Journal of antimicrobial chemotherapy.

Cytomegalovirus immunoglobulins in the prevention and treatment of cytomegalovirus disease.

D. Snydman, D. R. Snydman, 1990, Reviews of infectious diseases.

Cytomegalovirus Immune Globulin Prophylaxis in Liver Transplantation

S. Hammer, M. Kaplan, D. Snydman, 1993, Annals of Internal Medicine.

A multifaceted approach to education, observation, and feedback in a successful hand hygiene campaign.

D. Snydman, D. Fairchild, S. Doron, 2011, Joint Commission journal on quality and patient safety.

Characteristics and outcomes of neutropenia after orthotopic liver transplantation

L. Price, D. Snydman, R. Freeman, 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Shifting patterns in the epidemiology of nosocomial Candida infections.

D. Snydman, 2003, Chest.

Nosocomial infections in skilled nursing facilities: a preliminary survey.

D. Snydman, W. Hierholzer, E. Cohen, 1979, Public health reports.

D. Snydman, T. Ganz, F. Gordon, 2017, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Increased serum iron levels and infectious complications after liver transplantation.

D. Snydman, R. Ruthazer, B. Werner, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Lactobacillus GG as an Immune Adjuvant for Live Attenuated Influenza Vaccine in Healthy Adults: A Randomized Double Blind Placebo Controlled Trial

D. Snydman, L. Davidson, P. Hibberd, 2011, European Journal of Clinical Nutrition.

Avian Influenza A (H5N1) Infection in Eastern Turkey in 2006

D. Snydman, 2007 .

Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients

D. Snydman, A. Mehta, X. C. Liao, 2016, Antimicrobial Agents and Chemotherapy.

Bacterial Food Poisoning

D. Snydman, S. Gorbach, 1982 .

Fatal Toxic Shock Syndrome Associated with Clostridium sordellii after Medical Abortion

D. Snydman, 2007 .

Mortality Attributable to Nosocomial Clostridium difficile–Associated Disease During an Epidemic Caused by a Hypervirulent Strain in QuebecPépin J, Valiquette L, Cossette B (Univ of Sherbrooke, Quebec, Canada; Centre hospitalier universitaire de Sherbrooke, Quebec, Canada) CMAJ 173:1037–1041, 2005§

D. Snydman, 2006 .

Transmission of hepatitis B associated with hemodialysis: role of malfunction (blood leaks) in dialysis machines.

D. Snydman, W. London, B. Werner, 1976, The Journal of infectious diseases.

Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group.

D. Bates, K. Kahn, R. Platt, 1997, The Journal of infectious diseases.

Predicting Bacteremia in Patients with Sepsis Syndrome

R. Platt, D. Snydman, K. Sands, 1997 .

Horizontal Infection Control Strategy Decreases Methicillin-Resistant Staphylococcus aureus Infection and Eliminates Bacteremia in a Surgical ICU Without Active Surveillance*

S. Nasraway, F. Noubary, D. Snydman, 2014, Critical care medicine.

The impact of gown-use requirement on hand hygiene compliance.

S. Nasraway, D. Snydman, M. Tanios, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Repeated enzyme immunoassays have limited utility in diagnosing Clostridium difficile

D. Snydman, M. Drees, C. O'Sullivan, 2008, European Journal of Clinical Microbiology & Infectious Diseases.

The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.

D. Snydman, V. Yu, M. Wagener, 1996, The American journal of medicine.

Severe sepsis: variation in resource and therapeutic modality use among academic centers

D. Bates, K. Kahn, R. Platt, 2003, Critical care.

Multicenter Evaluation of the In Vitro Susceptibility of Staphylococci to Vancomycin

D. Snydman, M. Zervos, M. Hayden, 2006 .

In Vitro Evaluation of the Activity of Aztreonam-Avibactam against 341 Recent Clinical Isolates of Anaerobes

D. Snydman, L. Mcdermott, L. McDermott, 2021, Microbiology spectrum.

U.S.-Based National Surveillance for Fidaxomicin Susceptibility of Clostridioides difficile-Associated Diarrheal Isolates from 2013 to 2016

D. Snydman, B. A. Forbes, D. Gerding, 2019, Antimicrobial Agents and Chemotherapy.

Evaluation of the In Vitro Activity of Eravacycline against a Broad Spectrum of Recent Clinical Anaerobic Isolates

D. Snydman, T. Grossman, N. Jacobus, 2018, Antimicrobial Agents and Chemotherapy.

Characterization of pBFTM10, a clindamycin-erythromycin resistance transfer factor from Bacteroides fragilis

M. Malamy, D. Snydman, F. Tally, 1982, Journal of bacteriology.

Difference in absolute lymphocyte count among male and female heart transplant recipients

D. Snydman, J. Chow, Whitney A Perry, 2021, Clinical transplantation.

Association between lymphopenia at one month post-transplant and infectious outcomes or death in heart transplant recipients.

L. Price, J. Paulus, D. Snydman, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A nationwide survey of antimicrobial stewardship practices.

D. Snydman, L. Davidson, S. Doron, 2013, Clinical therapeutics.

Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007).

D. Snydman, J. Rosenblatt, V. Yu, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Total parenteral nutrition-related infections. Prospective epidemiologic study using semiquantitative methods.

D. Snydman, S. Kornfeld, S. Murray, 1982, The American journal of medicine.

Endocarditis and pericarditis complicating pneumococcal bacteraemia, with special reference to the adhesive abilities of pneumococci: results from a prospective study.

D. Snydman, J. Rello, V. Yu, 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

The effect of respiratory viral assay panel on antibiotic prescription patterns at discharge in adults admitted with mild to moderate acute exacerbation of COPD: a retrospective before- after study

D. Snydman, R. Ruthazer, S. Doron, 2019, BMC Pulmonary Medicine.

Prevention of Nosocomial Transmission of Respiratory Syncytial Virus in a Newborn Nursery

D. Snydman, K. Mcintosh, H. Meissner, 1988, Infection Control & Hospital Epidemiology.

Clinical Utility of Blood Cultures Drawn from Indwelling Central Venous Catheters in Hospitalized Patients with Cancer

D. Snydman, M. Falagas, D. Schenkein, 1999, Annals of Internal Medicine.

Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated

L. Price, D. Snydman, D. Poutsiaka, 2011, Bone Marrow Transplantation.

Blood Stream Infection (BSI) and Acute Graft Versus Host Disease (GVHD) after Hematopoietic Stem Cell Transplantation (HSCT) are Associated

L. Price, D. Snydman, D. Poutsiaka, 2007, Bone marrow transplantation.

Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality

L. Price, D. Snydman, K. Miller, 2006, Bone Marrow Transplantation.

Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients.

D. Snydman, K. Miller, D. Poutsiaka, 2007, The Journal of infection.

Clinical utility of blood cultures drawn from central venous or arterial catheters in critically ill surgical patients

S. Nasraway, D. Snydman, S. Supran, 2002, Critical care medicine.

Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial

D. Snydman, D. R. Snydman, 2007 .

Late incidence of cancer after metronidazole use: a matched metronidazole user/nonuser study.

D. Snydman, M. Falagas, A. Walker, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Iron storage indices: novel predictors of bacteremia in hemodialysis patients initiating intravenous iron therapy.

B. Jaber, D. Snydman, V. Balakrishnan, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

New developments in cytomegalovirus prevention and management.

D. Snydman, R. Rubin, B. Werner, 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Ridinilazole, a narrow spectrum antibiotic for treatment of Clostridioides difficile infection, enhances preservation of microbiota-dependent bile acids

Kyongbum Lee, D. Snydman, A. Kane, 2020, American journal of physiology. Gastrointestinal and liver physiology.

Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome.

J. Griffith, D. Snydman, D. Schenkein, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predicting high vancomycin minimum inhibitory concentration in methicillin-resistant Staphylococcus aureus bloodstream infections.

D. Snydman, R. Ruthazer, Y. Golan, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Evaluation of Vancomycin and Daptomycin Potency Trends (MIC Creep) against Methicillin-Resistant Staphylococcus aureus Isolates Collected in Nine U.S. Medical Centers from 2002 to 2006

Ronald N. Jones, D. Snydman, P. Fey, 2009, Antimicrobial Agents and Chemotherapy.

Iron storage indices and risk of bacterial infections in hemodialysis patients

B. Jaber, D. Snydman, V. Balakrishnan, 2004, Hemodialysis international. International Symposium on Home Hemodialysis.

Intra-abdominal infections: review of the bacteriology, antimicrobial susceptibility and the role of ertapenem in their therapy.

D. Snydman, E. Goldstein, 2004, The Journal of antimicrobial chemotherapy.

Transplant Infections, Raleigh A. Bowden, Per Ljungman, Carlos V. Paya (Eds.). Lippincott-Raven Publishers, Philadelphia (1998), 425, with illus, $145, (telephone: 800-777-2295),, ISBN: 0-397-58776-7

D. Snydman, M. Boeckh, P. Ljungman, 1999 .

Effect of Multivitamin and Multimineral Supplements on Morbidity From Infections in Older People (MAVIS trial): Pragmatic, Randomised, Double Blind, Placebo Controlled Trial

D. Snydman, 2006 .

Diagnosis and management of diarrhea in solid‐organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

D. Snydman, M. Angarone, 2019, Clinical transplantation.

Probable Person-to-Person Transmission of Avian Influenza A (H5N1)Ungchusak K, Auewarakul P, Dowell SF, et al (Thai Ministry of Public Health, Nonthaburi, Thailand; Mahidol Univ, Bangkok, Thailand; Ctrs for Disease Control and Prevention, Atlanta, Ga) N Engl J Med 352:333–340, 2005§

D. Snydman, 2006 .

A simultaneous outbreak of respiratory syncytial virus and parainfluenza virus type 3 in a newborn nursery.

D. Snydman, K. Mcintosh, H. Meissner, 1984, The Journal of pediatrics.

Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal Therapy

D. Snydman, 2006 .

Which renal transplant patients should receive cytomegalovirus immune globulin? A cost-effectiveness analysis.

S. Pauker, A. Levey, D. Snydman, 1991, Transplantation.

Protective Effects of the 23-Valent Pneumococcal Polysaccharide Vaccine in the Elderly Population: The EVAN-65 StudyVila-Córcoles A, and the EVAN Study Group (Catalonian Health Inst, Tarragona, Spain; et al) Clin Infect Dis 43:860–868, 2006§

D. Snydman, 2007 .

Infections Associated With Tumor Necrosis Factor-α Antagonists

D. Snydman, 2006 .

Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-Resistant Streptococcus pneumoniaeWhitney CG, for Active Bacterial Core Surveillance of the Emerging Infections Program Network (Ctrs for Disease Control and Prevention, Atlanta, Ga; et al) N Engl J Med 354:1455–1463, 2006§

D. Snydman, 2007 .

Counterpoint: prevention of cytomegalovirus (CMV) infection and CMV disease in recipients of solid organ transplants: the case for prophylaxis.

D. Snydman, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Determinants of Vancomycin Resistance and Mortality Rates in Enterococcal Bacteremia: A Prospective Multicenter Study

D. Snydman, M. Zervos, M. Wagener, 2001, Annals of Internal Medicine.

Prevention of catheter and intravascular device-related infections: a quality-of-care mandate for institutions and physicians.

D. Snydman, 2006, Mayo Clinic proceedings.

Epidemiologic trends in Clostridioides difficile isolate ribotypes in United States from 2011 to 2016.

D. Snydman, B. A. Forbes, D. Gerding, 2020, Anaerobe.

U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin

D. Snydman, B. A. Forbes, D. Gerding, 2015, Antimicrobial Agents and Chemotherapy.

An Epidemic, Toxin Gene–Variant Strain of Clostridium difficileMcDonald LC, Killgore GE, Thompson A, et al (Centers for Disease Control and Prevention, Atlanta, Ga; Univ of Vermont, Burlington; Loyola Univ, Hines, III) N Engl J Med 353:2433–2441, 2005§

D. Snydman, 2006 .

The impact of cefepime as first line therapy for neutropenic fever on Clostridium difficile rates among hematology and oncology patients.

D. Snydman, L. Epstein, S. Doron, 2013, Anaerobe.

Spectrum and significance of bacteremia due to Moraxella catarrhalis.

J. Ioannidis, D. Snydman, J. Griffiths, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Risk and safety of probiotics.

D. Snydman, S. Doron, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Lactobacillus GG: bacteriology and clinical applications.

D. Snydman, S. Gorbach, S. Doron, 2005, Gastroenterology clinics of North America.

A repeat offender: Recurrent extraintestinal Clostridium difficile infection following fecal microbiota transplantation.

D. Snydman, S. Walk, L. Mcdermott, 2018, Anaerobe.

Characterization ofpBFTM10, aClindamycin-Erythromycin Resistance Transfer Factor fromBacteroides fragilis

D. Snydman, F. Tally, M. Shimell, 1982 .

Plasmid-mediated, transferable resistance to clindamycin and erythromycin in Bacteroides fragilis.

M. Malamy, D. Snydman, S. Gorbach, 1979, The Journal of infectious diseases.

Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial.

D. Snydman, V. Yu, L. Mcdermott, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Evaluation of the in vitro activity of NVP-LMB415 against clinical anaerobic isolates with emphasis on the Bacteroides fragilis group.

D. Snydman, N. Jacobus, L. Mcdermott, 2005, The Journal of antimicrobial chemotherapy.

Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections

J. Griffith, D. Snydman, M. Falagas, 1996, European Journal of Clinical Microbiology and Infectious Diseases.

National survey on the susceptibility of Bacteroides Fragilis Group: report and analysis of trends for 1997-2000.

D. Snydman, R. Venezia, E. Goldstein, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Multicenter Study of In Vitro Susceptibility of theBacteroides fragilis Group, 1995 to 1996, with Comparison of Resistance Trends from 1990 to 1996

D. Snydman, S. Gorbach, S. Jenkins, 1999, Antimicrobial Agents and Chemotherapy.

Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994.

D. Snydman, V. Yu, S. Gorbach, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical importance of cefoxitin-resistant Bacteroides fragilis isolates.

D. Snydman, S. Gorbach, G. Cuchural, 1987, Diagnostic microbiology and infectious disease.

Demonstration of Borrelia burgdorferi in a patient with chronic Lyme arthritis.

D. Snydman, D. Schenkein, K. Pariser, 1986, Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology.

Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation.

D. Snydman, N. Flournoy, M. Levin, 1983, Annals of internal medicine.

Infective Endocarditis in Solid Organ Transplant Recipients

D. Snydman, Nina Singh, D. Paterson, 1998 .

Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study.

D. Snydman, V. Yu, M. Wagener, 1995, Archives of internal medicine.

An outbreak of hepatitis A among cancer patients treated with interleukin-2 and lymphokine-activated killer cells.

S. Hadler, R. Fisher, R. Karron, 1990, The Journal of infectious diseases.

Investigation of an Epidemic of Multi-Drug Resistant Pseudomonas aeruginosa

D. Snydman, Susan A. Murray, 1982, Infection Control.

Real-time antifungal susceptibility screening aids management of invasive yeast infections in immunocompromised patients.

D. Snydman, L. Mcdermott, José A. Martínez, 2002, The Journal of antimicrobial chemotherapy.

Clinical implications of multi-drug resistance in the intensive care unit.

D. Snydman, 1991, Scandinavian journal of infectious diseases. Supplementum.

Attributable mortality of Stenotrophomonas maltophilia bacteremia.

D. Snydman, P. Stark, L. Barefoot, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Attributable mortality of bacteremia associated with the Bacteroides fragilis group.

D. Snydman, M. Arbo, M. Redondo, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Evaluation of a two-stage testing algorithm for the diagnosis of respiratory viral infections

D. Snydman, S. Doron, A. Rabson, 2018, Diagnostic Microbiology and Infectious Disease.

Intravenous Tubing Containing Burettes Can Be Safely Changed at 72 Hour Intervals

D. Snydman, Maureen Donnelly-Reidy, Linda K. Perry, 1987, Infection Control.

Nosocomial Branhamella catarrhalis in a paediatric intensive care unit: risk factors for disease.

D. Snydman, D. Hecht, P. Cook, 1989, The Journal of hospital infection.

Antiviral Immunotherapy

D. Snydman, J. Desjardin, David R. Snydman, 1998, BioDrugs.

Nosocomial sepsis associated with interleukin-2.

D. Snydman, D. Parkinson, B. Sullivan, 1990, Annals of internal medicine.

Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy.

C. Crumpacker, R. Platt, D. Snydman, 1984, Annals of internal medicine.

Effect of Cytomegalovirus Infection Status on First-Year Mortality Rates among Orthotopic Liver Transplant Recipients

D. Snydman, M. Falagas, R. Ruthazer, 1997, Annals of Internal Medicine.

A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults

D. Snydman, 2006 .

Reemergence of Early Pandemic Staphylococcus aureus as a Community-acquired Meticillin-Resistant CloneRobinson DA, Kearns AM, Holmes A, et al (Univ of Bath, England; Health Protection Agency, London; Stobhill Hosp, Glasgow, Scotland; et al) Lancet 365:1256–1258, 2005§

D. Snydman, 2006 .

Progressive Multifocal Leukoencephalopathy in a Patient Treated With Natalizumab

D. Snydman, 2006 .

Microbial Identification Using DNA Target Amplification and Sequencing: Clinical Utility and Impact on Patient Management

D. Snydman, S. Doron, A. S. Joel Chandranesan, 2018, Open forum infectious diseases.

Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine

D. Snydman, 2007 .

Outcome of transplantation of organs procured from bacteremic donors.

D. Snydman, M. Falagas, F. Delmonico, 1999, Transplantation.

Mechanism of Resistance in Metronidazole

D. Snydman, A. Dhand, 2009 .

Toxin Production by an Emerging Strain of Clostridium difficile Associated With Outbreaks of Severe Disease in North America and Europe

D. Snydman, 2006 .

Hemodialysis-Associated Hepatitis in the United States, 1974

D. Snydman, D. Bregman, J. Bryan, 1977 .

Nosocomial viral hepatitis B. A cluster among staff with subsequent transmission to patients.

D. Snydman, J. Maynard, S. Hindman, 1976, Annals of internal medicine.

Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study

D. Snydman, 2006, BMJ : British Medical Journal.

Clinical Manifestations and Molecular Epidemiology of Late Recurrent Candidemia, and Implications for Management

D. Snydman, V. Yu, A. Morris, 2000, European Journal of Clinical Microbiology and Infectious Diseases.

The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland.

D. Snydman, M. Falagas, R. Rubin, 1997, The American journal of medicine.

A national survey of infectious disease practitioners on their use of outpatient parenteral antimicrobial therapy (OPAT)

K. Switkowski, G. Allison, D. Snydman, 2015, Infectious diseases.

A multivariate analysis of risk factors for hepatitis B virus infection among hospital employees screened for vaccination.

C. Crumpacker, R. Platt, D. Snydman, 1984, American journal of epidemiology.

SPECIAL SECTION: INFECTIONS IN TRANSPLANTATION AND OTHER IMMUNOCOMPROMISED HOSTS

D. Snydman, F. Delmonico, 2000 .

The potential role for iron overload and fungal infection in liver transplantation

D. Snydman, 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Aspergillus fumigatus infection of a biloma.

J. Ioannidis, D. Snydman, R. Freeman, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study

D. Snydman, J. Lundgren, J. Neaton, 2021, Transplant infectious disease : an official journal of the Transplantation Society.

Increasing Infectious Endocarditis Admissions Among Young People Who Inject Drugs

D. Snydman, A. Wurcel, K. Chui, 2016, Open forum infectious diseases.

Use of immune globulins in the prevention and treatment of infections.

D. Snydman, G. Siber, Siber Gr, 1992, Current clinical topics in infectious diseases.

Antiviral Agents: Action and Clinical Use

D. Snydman, T. Chang, 1979, Drugs.

Prevention of nosocomial viral hepatitis, type B (hepatitis B).

D. Snydman, R. Dixon, J. Bryan, 1975, Annals of internal medicine.

Fluconazole MIC and the Fluconazole Dose/MIC Ratio Correlate with Therapeutic Response among Patients with Candidemia

D. Snydman, V. Yu, A. Morris, 2005, Antimicrobial Agents and Chemotherapy.

Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection.

D. Snydman, I. Bica, R. Dhar, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparative In Vitro Activities of Daptomycin and Vancomycin against Resistant Gram-Positive Pathogens

D. Snydman, J. Boyce, N. Jacobus, 2000, Antimicrobial Agents and Chemotherapy.

The risk of cytomegalovirus infection in solid organ and bone marrow transplant recipients: transfusion of blood products

D. Snydman, E. Berkman, C. Hillyer, 1990, Transfusion.

Aspergillus brain abscess after liver transplantation with long-term survival. A case report.

D. Snydman, R. Freeman, R. Rohrer, 1994, Transplantation.

Clinical trial of piperacillin with acquisition of resistance by Pseudomonas and clinical relapse

D. Snydman, G. Simon, S. Gorbach, 1980, Antimicrobial Agents and Chemotherapy.

The clinical spectrum and treatment of Lyme disease.

A. Steere, S. Malawista, D. Snydman, 1984, The Yale journal of biology and medicine.

Destruction of isolates from the Pittsburgh Veterans Affairs Laboratory.

G. Sarosi, E. Anaissie, D. Snydman, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Bacteroides bivius and Bacteroides disiens in obstetrical patients: clinical findings and antimicrobial susceptibilities.

J. Bartlett, D. Snydman, S. Gorbach, 1981, The Journal of antimicrobial chemotherapy.

PREDICTIVE VALUE OF SURVEILLANCE SKIN CULTURES IN TOTAL-PARENTERAL-NUTRITION-RELATED INFECTION

D. Snydman, S. Murray, J. Majka, 1982, The Lancet.

Pneumocystis carinii and cytomegalovirus pneumonia in a previously healthy adult.

D. Snydman, B. Fanburg, S. Findlay, 1982, The American review of respiratory disease.

Reduced acquisition of vancomycin-resistant enterococci: gown effect or confounding?

D. Snydman, Y. Golan, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Incidence and predictors of cytomegalovirus pneumonia in orthotopic liver transplant recipients

D. Snydman, M. Falagas, R. Freeman, 1996 .

Risks and Epidemiology of Infections Associated with Ventricular Assist Devices and Heart Transplantation

D. Snydman, D. DeNofrio, A. Vest, 2016 .

Antifungal Prophylaxis for Solid Organ Transplant Recipients : Seeking Clarity Amidst Controversy

D. Snydman, 2022 .

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic‐Cell Transplantation

Michael Boeckh, Yoshinobu Kanda, Hermann Einsele, 2017, The New England journal of medicine.

High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation.

D. Kent, V. Martel-Laferrière, D. Snydman, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Epidemiology of sepsis syndrome in 8 academic medical centers.

D. Bates, K. Kahn, R. Platt, 1997, JAMA.

An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome.

D. Snydman, J. Rello, V. Yu, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Use of combination cytomegalovirus immune globulin plus ganciclovir for prophylaxis in CMV-seronegative liver transplant recipients of a CMV-seropositive donor organ: a multicenter, open-label study.

D. Snydman, M. Falagas, R. Freeman, 2001, Transplantation proceedings.

Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients.

A. Levey, F. Logerfo, D. Snydman, 1987, The New England journal of medicine.

Infection in solid organ transplantation

D. Snydman, 1999, Transplant infectious disease : an official journal of the Transplantation Society.

Prevention of cytomegalovirus-associated diseases with immunoglobulin.

D. Snydman, 1991, Transplantation Proceedings.

Leflunomide: a small step forward in meeting the urgent need for treatment of drug-resistant cytomegalovirus infection.

D. Snydman, 2010, Transplantation.

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation.

Angela M Caliendo, D. Snydman, A. Caliendo, 2010, Transplantation.

Hypogammaglobulinemia in Liver Transplant Recipients: Incidence, Timing, Risk Factors, and Outcomes

D. Snydman, R. Ruthazer, S. Doron, 2006, Transplantation.

Cytomegalovirus in Solid Organ Transplant Recipients

D. Snydman, A. Humar, A. Humar, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Impact of cytomegalovirus prophylaxis on rejection following orthotopic liver transplantation

D. Snydman, R. Freeman, R. Ruthazer, 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Historical overview of the use of cytomegalovirus hyperimmune globulin in organ transplantation

D. Snydman, 2001, Transplant infectious disease : an official journal of the Transplantation Society.

Cytomegalovirus prophylaxis in solid organ transplant recipients.

D. Snydman, R. Rubin, M. Pescovitz, 1996, Transplantation.

Preemptive Ganciclovir Therapy To Prevent Cytomegalovirus Disease in Cytomegalovirus Antibody-Positive Renal Transplant Recipients

D. Snydman, R. Rubin, J. Thistlethwaite, 1995, Annals of Internal Medicine.

Final analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus-immune globulin: comparison of the randomized and open-label trials.

D. Snydman, T. Strom, E. Milford, 1991, Transplantation proceedings.

Absolute Lymphocyte Count: A Predictor of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients

D. Kent, D. Snydman, R. Ruthazer, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Contemporary management of cytomegalovirus infection in transplant recipients: guidelines from an IHMF workshop, 2007.

D. Snydman, Nina Singh, P. Griffiths, 2008, Herpes : the journal of the IHMF.

Exposure to cytomegalovirus from the donated organ is a risk factor for bacteremia in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study Group.

J. Griffith, D. Snydman, M. Falagas, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Editorial Commentary: Chronic Lung Allograft Dysfunction in Lung Transplant Recipients: Another Piece of the Puzzle.

D. Snydman, B. Gardiner, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Viral Prophylaxis in Organ Transplant Patients

D. Snydman, S. Doron, M. Slifkin, 2005, Drugs.

The case for cytomegalovirus prophylaxis in solid organ transplantation

D. Snydman, 2006, Reviews in medical virology.

The clinical impact of ganciclovir prophylaxis on the occurrence of bacteremia in orthotopic liver transplant recipients.

D. Snydman, R. Freeman, R. Ruthazer, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Late and atypical cytomegalovirus disease in solid-organ transplant recipients.

D. Snydman, D. Poutsiaka, M. Slifkin, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection.

D. Snydman, M. Falagas, S. Supran, 1998, The Journal of infectious diseases.

Significance of cytomegalovirus for long-term survival after orthotopic liver transplantation: a prospective derivation and validation cohort analysis.

R. Wiesner, J. Griffith, D. Snydman, 1998, Transplantation.

Adenovirus infection in adult orthotopic liver transplant recipients: incidence and clinical significance.

D. Snydman, M. Falagas, R. Freeman, 1998, The Journal of infectious diseases.

Cytomegalovirus disease is associated with increased cost and hospital length of stay among orthotopic liver transplant recipients.

J. Griffith, D. Snydman, M. Falagas, 1997, Transplantation.

Ganciclovir therapy for cytomegalovirus disease associated with renal transplants.

D. Snydman, 1988, Reviews of infectious diseases.

A randomized, double-blind, placebo-controlled trial of valacyclovir prophylaxis to prevent zoster recurrence from months 4 to 24 after BMT

D. Snydman, K. Miller, K. Sprague, 2011, Bone Marrow Transplantation.

Clinical and epidemiological predictors of recurrent cytomegalovirus disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study Group.

D. Snydman, M. Falagas, R. Freeman, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical and epidemiological predictors of recurrent cytomegalovirus disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study Group.

D. Snydman, M. Falagas, R. Freeman, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Recurrent cytomegalovirus disease in solid-organ transplant recipients.

D. Snydman, M. Falagas, 1995, Transplantation proceedings.

Why did maribavir fail in stem-cell transplants?

D. Snydman, 2011, The Lancet. Infectious diseases.

Association between the presence of enterococcal virulence factors gelatinase, hemolysin, and enterococcal surface protein and mortality among patients with bacteremia due to Enterococcus faecalis.

D. Snydman, M. Zervos, J. Chow, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Selective method for identification and quantification of Bifidobacterium animalis subspecies lactis BB‐12 (BB‐12) from the gastrointestinal tract of healthy volunteers ingesting a combination probiotic of BB‐12 and Lactobacillus rhamnosus GG

D. Snydman, B. Goldin, A. Kane, 2017, Journal of applied microbiology.

Prediction model for 30-day hospital readmissions among patients discharged receiving outpatient parenteral antibiotic therapy.

David M Kent, J. Paulus, D. Kent, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Are we ready for an outpatient parenteral antimicrobial therapy bundle? A critical appraisal of the evidence.

G. Allison, D. Snydman, E. Muldoon, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

In Vitro Activities of Tigecycline against the Bacteroides fragilis Group

D. Snydman, R. Ruthazer, N. Jacobus, 2004, Antimicrobial Agents and Chemotherapy.

The efficacy of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bloodstream infection in patients with impaired renal function.

D. Snydman, C. Holcroft, Y. Golan, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B

D. Snydman, 2007 .

Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis BLai C-L, for the BEHoLD AI463027 Study Group (Queen Mary Hosp, Hong Kong; et al) N Engl J Med 354:1011–1020, 2006§

D. Snydman, 2007 .

Hepatitis in pregnancy.

D. Snydman, 1985, The New England journal of medicine.

Methicillin-Resistant S. aureus Infections among Patients in the Emergency DepartmentMoran GJ, for the EMERGEncy ID Net Study Group (Olive View-UCLA Med Ctr, Sylmar, Calif; et al) N Engl J Med 355:666–674, 2006§

D. Snydman, 2007 .

Organ donor screening for infectious diseases: review of practice and implications for transplantation.

D. Snydman, F. Delmonico, 1998, Transplantation.

Cytomegalovirus infection in organ transplant recipients.

D. Snydman, P. Hibberd, 1995, Infectious disease clinics of North America.

Epidemiology of infections after solid-organ transplantation.

D. Snydman, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Absence of antibodies to HTLV-III in health workers after hepatitis B vaccination.

C. Crumpacker, R. Platt, D. Snydman, 1985, JAMA.

Isolated antibody to hepatitis B surface antigen and response to hepatitis B vaccination.

C. Crumpacker, R. Platt, D. Snydman, 1985, Annals of internal medicine.

Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation.

D. Snydman, M. Territo, P. Chandrasekar, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Outpatient parenteral antimicrobial therapy (OPAT) in the republic of Ireland: results of a national survey

G. Allison, D. Snydman, C. Bergin, 2013, European Journal of Clinical Microbiology & Infectious Diseases.

Staphylococcus aureus Native Valve Infective Endocarditis: Report of 566 Episodes From the International Collaboration on Endocarditis Merged DatabaseMiro JM, and the International Collaboration on Endocarditis Merged Database Study Group (Univ of Barcelona; et al) Clin Infect Dis 41:507–514, 2005§

David R. Snydman, D. Snydman, 2006 .

Bacteroides bivius and Bacteroides disiens in obstetrical patients: clinical findings and antimicrobial susceptibilities

J. Bartlett, D. Snydman, S. Gorbach, 1980 .

Hemodialysis-associated hepatitis: report of an epidemic with further evidence on mechanisms of transmission.

D. Snydman, E. Macon, J. Bryan, 1976, American journal of epidemiology.

Immunologic Responses to Hepatitis B Virus and their Interpretations

C. Crumpacker, R. Platt, D. Snydman, 1984 .

Primary cytomegalovirus infection in liver transplant recipients: comparison of infections transmitted via donor organs and via transfusions. Boston Center for Liver Transplantation CMVIG Study Group.

D. Snydman, M. Falagas, R. Ruthazer, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A further analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus immune globulin: interim comparison of a randomized and an open-label trial.

D. Snydman, T. Strom, E. Milford, 1988, Transplantation proceedings.

Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome: Results From a Randomized, Double-blind, Placebo-Controlled Trial

R. F. Johnston, Robert W. Taylor, Steven C. Johnson, 1994 .

Infectious mononucleosis in an adult progressing to fatal immunoblastic lymphoma.

D. Snydman, A. Evans, J. Sullivan, 1982, Annals of internal medicine.

Cytomegalovirus infection in solid organ transplantation: Prospects for prevention

D. Snydman, 1990 .

Economic Impact of Piperacillin / Tazobactam in the Treatment of Suspected Polymicrobial Infections

D. Huse, D. Snydman, M. Russell, 2022 .

Predicting Clostridium difficile Stool Cytotoxin Results in Hospitalized Patients with Diarrhea

D. Bates, D. Katz, D. Snydman, 2006, Journal of General Internal Medicine.

Persistent babesiosis in a stem cell transplant recipient.

D. Snydman, K. Miller, Andrew S Lubin, 2011, Leukemia research.

Prevention and treatment of central venous catheter sepsis by exchange via a guidewire.

D. Snydman, 1984, Annals of surgery.

Netilmicin in Gram-Negative Bacterial Infections

D. Snydman, S. Gorbach, F. Tally, 1979, Antimicrobial Agents and Chemotherapy.

Evaluation of Vancomycin and Daptomycin Potency Trends (MIC Creep) against Methicillin-Resistant Staphylococcus aureus Isolates Collected in Nine U.S. Medical Centers from 2002 to 2006

Ronald N. Jones, D. Snydman, P. Fey, 2010, Antimicrobial Agents and Chemotherapy.

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group

Jerome J. Schentag, D. Snydman, R. Wunderink, 1994, Antimicrobial Agents and Chemotherapy.

Empiric antibiotic selection strategies for healthcare-associated pneumonia, intra-abdominal infections, and catheter-associated bacteremia.

D. Snydman, 2012, Journal of hospital medicine.

Correlation of Cytomegalovirus (CMV) Disease Severity and Mortality With CMV Viral Burden in CMV-Seropositive Donor and CMV-Seronegative Solid Organ Transplant Recipients

D. Snydman, N. Lewin-Koh, D. Sheinson, 2019, Open forum infectious diseases.

Antiviral treatment approaches for cytomegalovirus prevention in kidney transplant recipients: A systematic review of randomized controlled trials.

D. Snydman, Y. Murata, A. Raval, 2020, Transplantation reviews.

Epidemiology, risk factors, and outcomes associated with cytomegalovirus in adult kidney transplant recipients: A systematic literature review of real‐world evidence

D. Snydman, Y. Murata, A. Raval, 2020, Transplant infectious disease : an official journal of the Transplantation Society.

Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia.

D. Snydman, D. Hamer, I. Bica, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Limulus amebocyte lysate assay for detection of endotoxin in patients with sepsis syndrome. AMCC Sepsis Project Working Group.

D. Bates, K. Kahn, R. Platt, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Reactivation of Latent Cytomegalovirus Infection after Major Surgery: Risk Factors and Outcomes.

D. Snydman, J. Chow, B. Gardiner, 2019, Surgical infections.

Borrelia burgdorferi in joint fluid in chronic Lyme arthritis.

D. Snydman, D. Schenkein, K. Pariser, 1986, Annals of internal medicine.

Ocular and pericardial involvement in Legionnaires' disease.

D. Snydman, T. Hedges, R. Brown, 1984, The American journal of medicine.

Human Immunodeficiency Virus Infection in Hemodialysis Patients

J. B. Carey, P. Whelton, A. Levey, 1988 .

Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia.

D. Snydman, J. Rello, D. Hui, 2004, American journal of respiratory and critical care medicine.

The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1987.

D. Snydman, N. Jacobus, S. Finegold, 1990, The Journal of antimicrobial chemotherapy.

In Vitro Activities of Newer Quinolones against Bacteroides Group Organisms

D. Snydman, R. Venezia, E. Goldstein, 2002, Antimicrobial Agents and Chemotherapy.

Use of IgM-hepatitis A antibody testing. Investigating a common-source, food borne outbreak.

D. M. Ryan, D. Snydman, J. Dienstag, 1981, JAMA.

Acquired immunodeficiency syndrome with progressive multifocal leukoencephalopathy and monoclonal B-cell proliferation.

D. Snydman, P. Howley, D. McEniry, 1984, Annals of internal medicine.

Cytomegalovirus immune globulin for the prevention of primary CMV disease in renal transplant patients: analysis of usage under treatment IND status. The Treatment IND Study Group.

D. Snydman, R. Freeman, R. Kirkman, 1993, Transplantation proceedings.

Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.

J. Griffith, D. Snydman, M. Falagas, 1997, Clinical transplantation.

Use of cytomegalovirus immunoglobulin in multiply transfused premature neonates

D. Snydman, M. Levin, G. Grady, 1995, The Pediatric infectious disease journal.

Economic Consequences of Cytomegalovirus Disease Among Stem Cell Transplant Recipients

D. Snydman, E. Wu, Zhou Zhou, 2015 .

Comparative In Vitro Activities of Clinafloxacin and Trovafloxacin against 1,000 Isolates of Bacteroides fragilisGroup: Effect of the Medium on Test Results

D. Snydman, N. Jacobus, S. Supran, 2000, Antimicrobial Agents and Chemotherapy.

Antibiotic Exposure and Room Contamination Among Patients Colonized With Vancomycin-Resistant Enterococci

S. Nasraway, C. Schmid, D. Snydman, 2008, Infection Control & Hospital Epidemiology.

Enhanced preservation of the human intestinal microbiota by ridinilazole, a novel Clostridium difficile-targeting antibacterial, compared to vancomycin

D. Snydman, A. Kane, R. Vickers, 2018, PloS one.

Review of the efficacy of cytomegalovirus immune globulin in the prophylaxis of CMV disease in renal transplant recipients.

D. Snydman, 1993, Transplantation proceedings.

Intravenous tubing with burettes can be safely changed at 48-hour intervals.

D. Snydman, J. Stockman, H. Gorbea, 1984, JAMA.

Editorial commentary: the complexity of latent cytomegalovirus infection in stem cell donors.

D. Snydman, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hemophilus aphrophilus osteomyelitis.

D. Snydman, S. Soukiasian, W. H. Oh, 1984, The American journal of medicine.

Sputum: a diagnostic pitfall in alcoholics.

D. Snydman, S. Gorbach, 1978, Archives of internal medicine.

Capnocytophaga species: infections in nonimmunocompromised and immunocompromised hosts.

D. Snydman, D. Parenti, 1985, The Journal of infectious diseases.

In vitro evaluation of cytomegalovirus‐specific hyperimmune globulins vs. standard intravenous immunoglobulins

S. Miescher, D. Snydman, P. Lieby, 2015, Vox sanguinis.

Posttransplant microbiological surveillance.

D. Snydman, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

BACTERIA IN TOTAL PARENTERAL NUTRITION CATHETERS

D. Snydman, 1983, The Lancet.

Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006-2009.

D. Snydman, J. Rosenblatt, R. Venezia, 2011, Anaerobe.

The impact of CMV prevention on long‐term recipient and graft survival in heart transplant recipients: analysis of the Scientific Registry of Transplant Recipients (SRTR) database

D. Snydman, G. Bergman, P. Ulsh, 2011, Clinical transplantation.

Cytomegalovirus Prevention and Long-Term Recipient and Graft Survival in Pediatric Heart Transplant Recipients

D. Snydman, P. Ulsh, K. Kistler, 2010, Transplantation.

Association of human herpesvirus 6 reactivation with severe cytomegalovirus-associated disease in orthotopic liver transplant recipients.

D. Snydman, S. Supran, B. Werner, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prospective Observational Study Comparing Sepsis-2 and Sepsis-3 Definitions in Predicting Mortality in Critically Ill Patients

S. Nasraway, D. Snydman, J. Hudcová, 2019, Open forum infectious diseases.

Risk factors for death after sepsis in patients immunosuppressed before the onset of sepsis

D. Bates, K. Kahn, D. Snydman, 2009, Scandinavian journal of infectious diseases.

Surveillance cultures of blood, urine, and throat specimens are not valuable for predicting cytomegalovirus disease in liver transplant recipients. Boston Center for Liver Transplantation Cytomegalovirus Immune Globulin Study Group.

D. Snydman, M. Falagas, R. Ruthazer, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

In Vitro Evaluation of the Activity of Imipenem-Relebactam against 451 Recent Clinical Isolates of Bacteroides Group and Related Species

D. Snydman, N. Jacobus, L. McDermott, 2016, Antimicrobial Agents and Chemotherapy.

National Survey on the Susceptibility of Bacteroides fragilis Group: Report and Analysis of Trends in the United States from 1997 to 2004

N. V. Jacobus, R. Ruthazer, D. Snydman, 2007, Antimicrobial Agents and Chemotherapy.

Adults with Invasive Pneumococcal Disease: Missed Opportunities for VaccinationKyaw MH, and the Active Bacterial Core Surveillance Program of the Emerging Infections Program Network (Centers for Disease Control and Prevention, Atlanta, Ga; et al) Am J Prev Med 31:286–292, 2006§

D. Snydman, 2007 .

Changes in Invasive Pneumococcal Disease among HIV-Infected Adults Living in the Era of Childhood Pneumococcal ImmunizationFlannery B, Heffernan RT, Harrison LH, et al (Ctrs for Disease Control and Prevention, Atlanta, Ga; Connecticut Emerging Infections Program, Hartford; Johns Hopkins Bloomberg Sc

D. Snydman, 2007 .

Vancomycin‐Resistant Enterococcus Infections in Solid Organ Transplantation

D. Snydman, G. Patel, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci.

S. Nasraway, C. Schmid, D. Snydman, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Vancomycin-resistant enterococcal infections in bone marrow transplant recipients

D. Snydman, K. Miller, Y. Koç, 1998, Bone Marrow Transplantation.

Impact of provider-selected indication requirement on urine test utilization and positivity

A. Rodday, D. Snydman, S. Doron, 2022, Antimicrobial Stewardship and Healthcare Epidemiology.

Controlled trial to evaluate protection of high-risk infants against respiratory syncytial virus disease by using standard intravenous immune globulin

D. Snydman, G. Marx, D. Fulton, 1993, Antimicrobial Agents and Chemotherapy.

against Respiratory Syncytial Virus Disease by Using Standard Intravenous Immune Globulin

D. Snydman, D. Fulton, T. Hougen, 2003 .

Effecting the culture: Impact of changing urinalysis with reflex to culture criteria on culture rates and outcomes

A. Rodday, D. Snydman, S. Doron, 2022, Infection Control & Hospital Epidemiology.

Effecting the culture: Impact of changing urinalysis with reflex culture criteria on culture rates and outcomes

P. Sebastiani, A. Rodday, D. Snydman, 2022, Antimicrobial Stewardship & Healthcare Epidemiology.

Influence of blood culture results on antibiotic choice in the treatment of bacteremia.

D. Snydman, M D Arbo, D R Snydman, 1994, Archives of internal medicine.

Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group

D. Snydman, M. Falagas, L. McDermott, 1997, Antimicrobial agents and chemotherapy.

Pseudobacteremia: false-positive blood cultures from mist tent contamination.

D. Snydman, S. Rubin, M. Måløy, 1977, American journal of epidemiology.

Daptomycin for line-related Leuconostoc bacteraemia.

D. Snydman, D. Poutsiaka, S. Hadley, 2001, The Journal of antimicrobial chemotherapy.

Relationship of pulmonary artery catheter use to mortality and resource utilization in patients with severe sepsis*

D. Bates, K. Kahn, R. Platt, 2003, Critical care medicine.

Carbapenem-resistant enterobacteriaceae: analyzing knowledge and practice in healthcare providers

D. Snydman, S. Doron, J. Schimmel, 2014, PeerJ.

Female sex and advanced age are associated with invasive cytomegalovirus disease in solid organ transplant recipients

D. Snydman, M. Rodriguez-Garcia, J. Chow, 2022, Transplant infectious disease : an official journal of the Transplantation Society.

Sex- and age-based comparison of serum immunoglobulins following liver transplantation.

D. Snydman, J. Chow, Whitney A Perry, 2023, Transplant immunology.

Transmission of vancomycin-resistant enterococcus in a neonatal intensive care unit.

D. Snydman, S. Doron, Y. Golan, 2005, The Pediatric infectious disease journal.

In Vitro Susceptibilities of the Bacteroides fragilis Group Species: Change in Isolation Rates Significantly Affects Overall Susceptibility Data

D. Snydman, R. Venezia, E. Goldstein, 2002 .

Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin: a retrospective analysis

D. Snydman, G. Cuchural, M. Gill, 1992, Antimicrobial Agents and Chemotherapy.

Pretransplant lymphopenia is a novel prognostic factor in cytomegalovirus and noncytomegalovirus invasive infections after liver transplantation

D. Snydman, R. Freeman, D. Poutsiaka, 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

In Vitro Activity of Ceftaroline against a Broad Spectrum of Recent Clinical Anaerobic Isolates

D. Snydman, N. Jacobus, L. McDermott, 2010, Antimicrobial Agents and Chemotherapy.

Infection risk with alemtuzumab decreases over time: pooled analysis of 6-year data from the CAMMS223, CARE-MS I, and CARE-MS II studies and the CAMMS03409 extension study

Jeffrey A. Cohen, D. Arnold, D. Snydman, 2018, Multiple sclerosis.

Evaluation in a Multicenter, Prospective, Observational Study

D. Snydman, V. Yu, M. Wagener, 2017 .

Activity of Ceftolozane-Tazobactam against a Broad Spectrum of Recent Clinical Anaerobic Isolates

D. Snydman, N. Jacobus, L. McDermott, 2013, Antimicrobial Agents and Chemotherapy.

a Broad Spectrum of Recent Clinical Activity of Ceftolozane-Tazobactam against

D. Snydman, L. McDermott, 2014 .

Emergence of fluoroquinolone resistance among Bacteroides species.

D. Snydman, R. Venezia, E. Goldstein, 2003, The Journal of antimicrobial chemotherapy.

Antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1989.

D. Snydman, S. Finegold, J. Rihs, 1992, Clinical therapeutics.

No Evidence of Harms of Probiotic Lactobacillus rhamnosus GG ATCC 53103 in Healthy Elderly—A Phase I Open Label Study to Assess Safety, Tolerability and Cytokine Responses

C. Fraser, D. Snydman, G. Solano-Aguilar, 2014, PloS one.

Hemodialysis-associated hepatitis in the United States--1972.

D. Snydman, J. Bryan, B. Hanson, 1975, The Journal of infectious diseases.

Reactivation of latent cytomegalovirus infection in patients with rheumatologic disease: a case–control study

D. Snydman, J. Chow, B. Gardiner, 2019, Rheumatology International.

Monotherapy is appropriate for nosocomial pneumonia in the intensive care unit.

D. Snydman, M. Arbo, Manuel D. J. Arbo, 1993, Seminars in respiratory infections.

Ganciclovir for treatment of renal transplant-associated primary cytomegalovirus pneumonia.

C. Crumpacker, D. Snydman, D. Hecht, 1988, The Journal of infectious diseases.

Resource Utilization Among Patients With Sepsis Syndrome

D. Bates, K. Kahn, R. Platt, 2003, Infection Control & Hospital Epidemiology.

Cytomegalovirus immune globulin after liver transplantation: a cost‐effectiveness analysis 1

C. Schmid, S. Pauker, D. Snydman, 2000, Clinical transplantation.

Activity of a Novel Cyclic Lipopeptide, CB-183,315, against Resistant Clostridium difficile and Other Gram-Positive Aerobic and Anaerobic Intestinal Pathogens

D. Snydman, N. Jacobus, L. McDermott, 2012, Antimicrobial Agents and Chemotherapy.

Moxifloxacin versus Ethambutol in the First 2 Months of Treatment for Pulmonary Tuberculosis

D. Snydman, 2007 .

Prophylaxis and treatment of cytomegalovirus disease in recipients of solid organ transplants: current approach and future challenges

D. Snydman, Y. Puius, 2007, Current opinion in infectious diseases.

In Vitro Activities of Doripenem, a New Broad-Spectrum Carbapenem, against Recently Collected Clinical Anaerobic Isolates, with Emphasis on the Bacteroides fragilis Group

D. Snydman, N. Jacobus, L. McDermott, 2008, Antimicrobial Agents and Chemotherapy.

The impact of recurrent cytomegalovirus infection on long‐term survival in solid organ transplant recipients

D. Snydman, S. Brilleman, A. Peleg, 2019, Transplant infectious disease : an official journal of the Transplantation Society.

Role of Secondary Prophylaxis With Valganciclovir in the Prevention of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients

L. Price, D. Kent, D. Snydman, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cytomegalovirus prophylaxis strategies in high-risk transplantation.

D. Snydman, 1994, Transplantation Proceedings.

Epidemiologic Trends in Clostridium difficile Isolate Ribotypes in United States from 2010 to 2014

D. Snydman, B. A. Forbes, Robin Patel, 2017, Open Forum Infectious Diseases.

Physician report cards and rankings yield long-lasting hand hygiene compliance exceeding 90 %

S. Nasraway, D. Snydman, S. Doron, 2015, Critical Care.

Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing nonnucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: openlabel randomised trial

D. Snydman, 2007 .

Carbapenem-Resistant Enterobacteriaceae: A Statewide Survey of Detection in Massachusetts Hospitals

D. Snydman, A. DeMaria, R. Duncan, 2012, Infection Control & Hospital Epidemiology.

Prevention of catheter-related bloodstream infections: looking to the department of veterans affairs health care system for guidance.

D. Snydman, 2007, Mayo Clinic proceedings.

Effect of Lactobacillus rhamnosus GG Administration on Vancomycin-Resistant Enterococcus Colonization in Adults with Comorbidities

D. Snydman, B. Goldin, S. Doron, 2015, Antimicrobial Agents and Chemotherapy.

Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIVGallant JE, for the Study 934 Group (Johns Hopkins Univ, Baltimore, Md; et al) N Engl J Med 354:251–260, 2006§

D. Snydman, 2007 .

ANALYSIS OF THE IN VITRO ACTIVITY OF TROVAFLOXACIN (CP‐99,219) AGAINST BACTEROIDES SPECIES

D. Snydman, L. McDermott, 1996 .

Nosocomial Hepatitis C: More of a Hidden Epidemic

D. Snydman, A. DeMaria, 2012, Annals of Internal Medicine.

A pilot trial of a novel cytomegalovirus immune globulin in renal transplant recipients.

F. Logerfo, D. Snydman, G. Grady, 1984, Transplantation.

Prevention of cytomegalovirus disease in transplant recipients

D. Snydman, M. Falagas, 1996, The Lancet.

Prevention of cytomegalovirus disease with intravenous immune globulin

D. Snydman, 1991 .

Vancomycin-resistant enterococcal infections in bone marrow transplant recipients

D. Snydman, K. Miller, Y. Koç, 1998 .

Antiviral immunotherapy: a review of current status.

D. Snydman, J. Desjardin, 1998, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

Severe Sepsis: Variation in Resource and Therapeutic Modality use Among Academic Centers

D. Bates, K. Kahn, R. Platt, 2003 .

Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings.

C. Crumpacker, R. Platt, D. Snydman, 1986, Annals of internal medicine.

Evaluation of In Vitro Interaction of Daptomycin with Gentamicin or Beta-lactam Antibiotics Against taphylococcus aureus and Enterococci by FIC Index and Timed-Kill Curves

D. Snydman, N. Jacobus, L. McDermott, 2005, Journal of chemotherapy.

Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients

D. Snydman, A. Mehta, C. Rosenberger, 2016, Antimicrobial Agents and Chemotherapy.

Differences in the Molecular Epidemiology and Antibiotic Susceptibility of Clostridium difficile Isolates in Pediatric and Adult Patients

D. Snydman, D. Gerding, D. Hecht, 2016, Antimicrobial Agents and Chemotherapy.

Editorial commentary: Use of valganciclovir for prevention and treatment of cytomegalovirus disease.

D. Snydman, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus

D. Snydman, 2007 .

Infective endocarditis in solid organ transplant recipients.

D. Snydman, Nina Singh, D. Paterson, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prospective Observational Study Comparing Sepsis-2 and Sepsis-3 Definitions in Predicting Mortality in Critically Ill Patients

S. Nasraway, D. Snydman, S. Doron, 2019, Open forum infectious diseases.

Incidence and predictors of cytomegalovirus pneumonia in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study Group.

D. Snydman, M. Falagas, R. Freeman, 1996, Transplantation.

Risk and safety of probiotics.

D. Snydman, S. Doron, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Use of Gastric Acid–Suppressive Agents and the Risk of Community-Acquired Clostridium difficile–Associated Disease

D. Snydman, D. R. Snydman, D. R. Snydman, 2006 .

Prevention of cytomegalovirus disease in recipients of solid-organ transplants.

D. Snydman, C. Payá, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Ertapenem Versus Piperacillin/Tazobactam for Diabetic Foot Infections (SIDESTEP): Prospective, Randomized, Controlled, Double-blinded, Multicentre TrialLipsky BA, Armstrong DG, Citron DM, et al (Univ of Washington, Seattle; Rosalind Franklin Univ of Medicine and Science, Chicago; RM Alden Research L

D. Snydman, 2006 .

Human herpesviruses 6 and 7 in solid organ transplant recipients.

D. Snydman, V. Emery, Vincent C. Emery, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Factors associated with neutropenia post heart transplantation

D. Snydman, R. Ruthazer, H. Boucher, 2021, Transplant infectious disease : an official journal of the Transplantation Society.

No Evidence of Harms of Probiotic Lactobacillus rhamnosus GG ATCC 53103 in Healthy Elderly—A Phase I Open Label Study to Assess Safety, Tolerability and Cytokine Responses

C. Fraser, D. Snydman, G. Solano-Aguilar, 2014, PloS one.

In Vitro Evaluation of the Activity of Imipenem-Relebactam against 451 Recent Clinical Isolates of Bacteroides Group and Related Species

D. Snydman, N. Jacobus, L. McDermott, 2016, Antimicrobial Agents and Chemotherapy.

Destruction of isolates from the Pittsburgh Veterans Affairs Laboratory.

G. Sarosi, E. Anaissie, D. Snydman, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Capnocytophaga infection involving a portal-systemic vascular shunt

Sanjeev Arora, D. Snydman, K. A. Mello, 1990, Digestive Diseases and Sciences.

Historical perspective of Lyme disease.

A. Steere, S. Malawista, D. Snydman, 1986, Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology.

Management and Outcomes of a First Recurrence of Clostridium difficile–Associated Disease in Quebec, Canada

D. Snydman, 2007 .

A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults

D. Snydman, 2006 .

First report of a left ventricular assist device infection caused by Staphylococcus schleiferi subspecies coagulans: a coagulase-positive organism.

D. Snydman, H. Boucher, D. DeNofrio, 2012, Diagnostic microbiology and infectious disease.

Methicillin-Resistant Staphylococcus aureus Disease in Three Communities

D. Snydman, 2006 .

Hepatitis B infection from medical personnel.

D. Snydman, 1976, JAMA.